Shattuck Labs (STTK) Non-Current Assets (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Non-Current Assets of $8.4 million for Q1 2026, down 22.26% year-over-year from $10.8 million in Q1 2025, and down 2.14% quarter-over-quarter from $8.6 million in Q4 2025.
Shattuck Labs (STTK) Non-Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Non-Current Assets for 8 consecutive years, with $8.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 22.26% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $36.2 million (down 27.21% YoY), while the FY2025 annual figure was $8.6 million, down 27.74% from the prior year.
- Non-Current Assets fell to $8.4 million in Q1 2026 per STTK's latest filing, from $8.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $21.9 million in Q2 2022 and bottomed at $8.4 million in Q1 2026.
- Historically, Non-Current Assets has averaged $14.9 million across 5 years, with a median of $15.3 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 177.44% — and 2025, when it sank 31.67%.
- Shattuck Labs' Non-Current Assets stood at $20.7 million in 2022, then retreated by 21.2% to $16.3 million in 2023, then dropped by 27.59% to $11.8 million in 2024, then fell by 27.74% to $8.6 million in 2025, then fell by 2.14% to $8.4 million in 2026.
- Business Quant data shows STTK's Non-Current Assets at $8.4 million in Q1 2026, $8.6 million in Q4 2025, and $9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 7.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.39 Mn |
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 8.55 Mn |
| Sep 30, 2025 | 9.61 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 10.76 Mn |
| Dec 31, 2024 | 11.83 Mn |
| Sep 30, 2024 | 12.98 Mn |
| Jun 30, 2024 | 14.19 Mn |
| Mar 31, 2024 | 15.26 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 17.47 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 19.84 Mn |
| Dec 31, 2022 | 20.74 Mn |
| Sep 30, 2022 | 21.43 Mn |
| Jun 30, 2022 | 21.92 Mn |
| Mar 31, 2022 | 15.50 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 8.92 Mn |